Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MyoCell Implantation in CHF Post-MI
NCT00526253Phase 3Unknown
- Sponsor
- Bioheart, Inc.
- Start
- Sep 2007
- Primary completion
- Feb 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of MyoCell in heart failure (HF), sponsored by Bioheart, Inc.. Status: unknown.
02
Drugs
MyoCell
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00526253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526253.